Literature DB >> 23634919

Intracranial hemorrhage from dural arteriovenous fistulas: clinical features and outcome.

David J Daniels1, Ananth K Vellimana, Gregory J Zipfel, Giuseppe Lanzino.   

Abstract

OBJECT: In this paper the authors' goal was to review the clinical features and outcome of patients with intracranial dural arteriovenous fistulas (DAVFs) who presented with hemorrhage.
METHODS: A retrospective study of 28 patients with DAVFs who presented with intracranial hemorrhage to 2 separate institutions was performed. The information reviewed included clinical presentation, location and size of hemorrhage, angiographic features, treatment, and clinical and radiologically documented outcomes. Clinical and radiological follow-up were available in 27 of 28 patients (mean follow-up 17 months).
RESULTS: The vast majority of patients were male (86%), and the most common presenting symptom was sudden-onset headache. All DAVFs had cortical venous drainage, and about one-third were associated with a venous varix. The most common location was tentorial (75%). Treatment ranged from endovascular (71%), surgical (43%), Gamma Knife surgery (4%), or a combination of modalities. The majority of fistulas (75%) were completely obliterated, and most patients experienced excellent clinical outcome (71%, modified Rankin Scale score of 0 or 1). There were no complications in this series.
CONCLUSIONS: Case series, including the current one, suggest that the vast majority of patients who present with intracranial hemorrhage from a DAVF are male. The most common location for DAVFs presenting with hemorrhage is tentorial. Excellent outcomes are achieved with individualized treatment, which includes various therapeutic strategies alone or in combination. Despite the hemorrhagic presentation, almost two-thirds of patients experience a full recovery with no or minimal residual symptoms.

Entities:  

Mesh:

Year:  2013        PMID: 23634919     DOI: 10.3171/2013.4.FOCUS1335

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  14 in total

1.  Changing Clinical and Therapeutic Trends in Tentorial Dural Arteriovenous Fistulas: A Systematic Review.

Authors:  D Cannizzaro; W Brinjikji; S Rammos; M H Murad; G Lanzino
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-27       Impact factor: 3.825

2.  Surgical treatment for ruptured dural arteriovenous fistula with large intracranial hematoma.

Authors:  Xianwang Ye; Haifeng Wang; Yi Huang; Shengjun Zhou; Xiang Gao
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Endovascular Treatment of Intracranial Dural Arteriovenous Fistulas Presenting with Intracranial Hemorrhage in 46 Consecutive Patients: With Emphasis on Transarterial Embolization with Onyx.

Authors:  C Li; X Yang; Y Li; C Jiang; Z Wu
Journal:  Clin Neuroradiol       Date:  2014-12-13       Impact factor: 3.649

4.  Anterior Cranial Fossa Dural Arteriovenous Fistula Presenting as Recurrent Multifocal Lobar Intracerebral Hemorrhages: A Case Report.

Authors:  Stephen Abraham Johnson; Benjamin Cox; Mai Lan Ho; Meghan Murphy; Eugene Scharf
Journal:  Neurohospitalist       Date:  2018-09-04

Review 5.  Intracranial Dural Arteriovenous Fistulae.

Authors:  Matthew R Reynolds; Giuseppe Lanzino; Gregory J Zipfel
Journal:  Stroke       Date:  2017-05       Impact factor: 7.914

6.  A hemorrhagic complication after Onyx embolization of a tentorial dural arteriovenous fistula: A caution about subdural extension with pial arterial supply.

Authors:  Kenichi Sato; Yasushi Matsumoto; Hidenori Endo; Teiji Tominaga
Journal:  Interv Neuroradiol       Date:  2017-01-01       Impact factor: 1.610

7.  Safety of Thrombolysis in a Patient with an Intracranial Dural Arteriovenous Fistula.

Authors:  Ana João Pissarra; Mariana Malheiro; Carolina Gouveia; Patrícia Vicente; Leonor Matos
Journal:  Eur J Case Rep Intern Med       Date:  2019-01-14

8.  Risk of Early Versus Later Rebleeding From Dural Arteriovenous Fistulas With Cortical Venous Drainage.

Authors:  Andrew J Durnford; Danyal Akarca; David Culliford; John Millar; Ridhima Guniganti; Enrico Giordan; Waleed Brinjikji; Ching-Jen Chen; Isaac Josh Abecassis; Michael Levitt; Adam J Polifka; Colin P Derdeyn; Edgar A Samaniego; Amanda Kwasnicki; Ali Alaraj; Adriaan R E Potgieser; Stephanie Chen; Yoshiteru Tada; Ryan Phelps; Adib Abla; Junichiro Satomi; Robert M Starke; J Marc C van Dijk; Sepideh Amin-Hanjani; Minako Hayakawa; Bradley Gross; W Christopher Fox; Louis Kim; Jason Sheehan; Giuseppe Lanzino; Akash P Kansagra; Rose Du; Rosalind Lai; Gregory J Zipfel; Diederik O Bulters
Journal:  Stroke       Date:  2022-04-14       Impact factor: 10.170

9.  Clinical and Angioarchitectural Risk Factors Associated with Intracranial Hemorrhage in Dural Arteriovenous Fistulas: A Single-Center Retrospective Study.

Authors:  Chuanhui Li; Yang Wang; Youxiang Li; Chuhan Jiang; Xinjian Yang; Zhongxue Wu
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

Review 10.  Outcome after intracranial haemorrhage from dural arteriovenous fistulae; a systematic review and case-series.

Authors:  W M T Jolink; J M C van Dijk; C J J van Asch; G A P de Kort; A Algra; R J M Groen; G J E Rinkel; C J M Klijn
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.